Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time

European Journal of Neuroscience

Volumn 19, Issue 8, 2004, Pages 2249-2260

  Taymans, Jean Marc ^a,b   Kia, Hossein Kami ^a   Claes, Robby ^a   Cruz, Catarina ^a   Leysen, Josée ^a,b   Langlois, Xavier ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Haloperidol; Quinpirole; Rat; SCH23390; SKF38393; SKF82958

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; MESSENGER RNA; PRESYNAPTIC RECEPTOR; QUINPIROLE; RGS PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; UPREGULATION;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MALE; NEURAL PATHWAYS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RGS PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 2342469971     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0953-816X.2004.03336.x     Document Type: Article

References (50)

1. Aizman, O., Brismar, H., Uhlen, P., Zettergren, E., Levey, A.I., Forssberg, H., Greengard, P. & Aperia, A. (2000) Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat. Neurosci., 3, 226-230.
2. Berke, J.D., Paletzki, R.F., Aronson, G.J., Hyman, S.E. & Gerfen, C.R. (1998) A complex program of striatal gene expression induced by dopaminergic stimulation. J. Neurosci., 18, 5301-5310.
3. Berman, D.M., Wilkie, T.M. & Gilman, A.G. (1996) GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell, 86, 445-452.
4. Blandini, F., Fancellu, R., Orzi, F., Conti, G., Greco, R., Tassorelli, C. & Nappi, G. (2003) Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex. Eur. J. Neurosci., 17, 763-770.
5. Burchett, S.A., Volk, M.L., Bannon, M.J. & Granneman, J.G. (1998) Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine. J. Neurochem., 70, 2216-2219.
6. Burchett, S.A., Bannon, M.J. & Granneman, J.G. (1999) RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. J Neurochem., 72, 1529-1533.
7. Chritin, M., Feuerstein, C. & Savasta, M. (1993) Time-course of changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat. Brain Res. Mol. Brain Res., 19, 318-322.
8. Deumens, R., Blokland, A. & Prickaerts, J. (2002) Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol., 175, 303-317.
9. De Vries, L., Zheng, B., Fischer, T., Elenko, E. & Farquhar, M.G. (2000) The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol., 40, 235-271.
10. Dragunow, M., Robertson, G.S., Faull, R.L., Robertson, H.A. & Jansen, K. (1990) D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience, 37, 287-294.
11. Dumartin, B., Caille, I., Gonon, F. & Bloch, B. (1998) Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists. J. Neurosci., 18, 1650-1661.
12. Garris, P.A., Budygin, E.A., Phillips, P.E., Venton, B.J., Robinson, D.L., Bergstrom, B.P., Rebec, G.V. & Wightman, R.M. (2003) A role for pre-synaptic mechanisms in the actions of nomifensine and haloperidol. Neuroscience, 118, 819-829.
13. Gerfen, C.R. & Wilson, C.J. (1996) The basal ganglia. In Swanson, L.W., Björklund, A. & Hökfelt, T. (Eds), Integrated Systems of the CNS, Part III. Elsevier Science, Amsterdam, pp. 371-468.
14. Geurts, M., Hermans, E. & Maloteaux, J.M. (2002) Opposite modulation of regulators of G protein signalling-2 (RGS2) and RGS4 expression by dopamine receptors in the rat striatum. Neurosci. Lett., 333, 146-150.
15. Geurts, M., Maloteaux, J.M. & Hermans, E. (2003) Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. Biochem. Pharmacol., 66, 1163-1170.
16. Gnanalingham, K.K., Hunter, A.J., Jenner, P. & Marsden, C.D. (1995) Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat - relationship to circling behaviour. Biochem. Pharmacol., 493, 1185-1193.
17. Gold, S.J., Heifets, B.D., Pudiak, C.M., Potts, B.W. & Nestler, E.J. (2002) Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizures. J. Neurochem., 82, 828-838.
18. Gold, S.J., Han, M.H., Herman, A.E., Ni, Y.G., Pudiak, C.M., Aghajanian, G.K., Liu, R.J., Potts, B.W., Mumby, S.M. & Nestler, E.J. (2003) Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur. J. Neurosci., 17, 971-980.
19. Hoffman, A.F., Zahniser, N.R., Lupica, C.R. & Gerhardt, G.A. (1999) Voltage-dependency of the dopamine transporter in the rat substantia nigra. Neurosci. Lett., 260, 105-108.
20. Hollinger, S. & Hepler, J.R. (2002) Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev., 54, 527-559.
21. Hömme, M., Schmitt, C.P., Himmele, R., Hoffmann, G.F., Mehls, O. & Schaefer, F. (2003) Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells. Endocrinology, 144, 2496.
22. Imperato, A. & Di Chiara, G. (1988) Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur. J. Pharmacol., 156, 385-393.
23. Imperato, A., Mulas, A. & Di Chiara, G. (1987) The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Eur. J. Pharmacol., 142, 177-181.
24. Imperato, A., Tanda, G., Frau, R. & Di Chiara, G. (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J. Pharmacol. Exp. Ther., 245, 257-264.
25. Ingi, T., Krumins, A.M., Chidiac, P., Brothers, G.M., Chung, S., Snow, B.E., Barnes, C.A., Lanahan, A.A., Siderovski, D.P., Ross, E.M., Gilman, A.G. & Worley, P.F. (1998) Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J. Neurosci., 18, 7178-7188.
26. Kia, H.K., Krebs, C.J., Koibuchi, N., Chin, W.W. & Pfaff, D.W. (2001) Co-expression of estrogen and thyroid hormone receptors in individual hypothalamic neurons. J. Comp. Neurol., 437, 286-295.
27. Koelle, M.R. & Horvitz, H.R. (1996) EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell, 84, 115-125.
28. Nakazato, E., Ohno, M. & Watanabe, S. (1998) MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum. Eur. J. Pharmacol., 342, 209-212.
29. O'Boyle, K.M., Gaitanopoulos, D.E., Brenner, M. & Waddington, J.L. (1989) Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology, 28, 401-405.
30. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
31. Robertson, G.S., Tham, C.S., Wilson, C., Jakubovic, A. & Fibiger, H.C. (1993) In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. J. Pharmacol. Exp. Ther., 264, 1344-1351.
32. Robinet, E.A., Geurts, M., Maloteaux, J.M. & Pauwels, P.J. (2001a) Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA. Neurosci. Lett., 307, 45-48.
33. Robinet, E.A., Wurch, T. & Pauwels, P.J. (2001b) Different regulation of RGS2 mRNA by haloperidol and clozapine. Neuroreport, 12, 1731-1735.
34. Rocha, B.A., Fumagalli, F., Gainetdinov, R.R., Jones, S.R., Ator, R., Giros, B., Miller, G.W. & Caron, M.G. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci., 1, 132-137.
35. Rushlow, W.J., Rajakumar, B., Flumerfelt, B.A., Naus, C.C. & Rajakumar, N. (2000) Changes in CArG-binding protein A expression levels following injection(s) of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat. Neuroscience, 98, 69-78.
36. Salim, S., Sinnarajah, S., Kehrl, J.H. & Dessauer, C.W. (2003) Identification of RGS2 and Type Vadenylyl cyclase interaction sites. J. Biol. Chem., 278, 15 842-15 849.
37. Schotte, A., Janssen, P.F., Gommeren, W., Luyten, W.H., Van Gompel, P., Lesage, A.S., De Loore, K. & Leysen, J.E. (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology, 124, 57-73.
38. See, R.E., Sorg, B.A., Chapman, M.A. & Kalivas, P.W. (1991) In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology, 30, 1269-1274.
39. Sibley, D.R. & Neve, K.A. (1997) Regulation of dopamine receptor function and expression. In Neve, K.A. & Neve, R.L. (Eds), The Dopamine Receptors. Humana Press, Totowa, NJ, pp. 383-424.
40. Siderovski, D.P., Strockbine, B. & Behe, C.I. (1999) Whither goest the RGS proteins? Crit. Rev. Biochem. Mol. Biol., 34, 215-251.
41. Sinnarajah, S., Dessauer, C.W., Srikumar, D., Chen, J., Yuen, J., Yilma, S., Dennis, J.C., Morrison, E.E., Vodyanoy, V. & Kehrl, J.H. (2001) RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature, 409, 1051-1055.
42. Starke, K., Gothert, M. & Kilbinger, H. (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev., 69, 864-989.
43. Steiner, H. & Kitai, S.T. (2000) Regulation of rat cortex function by D1 dopamine receptors in the striatum. J. Neurosci., 20, 5449-5460.
44. Surmeier, D.J., Yan, Z. & Song, W.J. (1998) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Adv. Pharmacol., 42, 1020-1023.
45. Taylor, M.D., de Ceballos, M.L., Jenner, P. & Marsden, C.D. (1991) Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat. Biochem. Pharmacol., 41, 1385-1391.
46. Taymans, J.M., Wintmolders, C., Te Riele, P., Jurzak, M., Groenewegen, H.J., Leysen, J.E. & Langlois, X. (2002) Detailed localization of regulator of G protein signaling 2 messenger ribonucleic acid and protein in the rat brain. Neuroscience, 114, 39-53.
47. Taymans, J.-M., Leysen, J.E. & Langlois, X. (2003) Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions. J. Neurochem., 84, 1118-1127.
48. Tomiyama, K., Koshikawa, N., Funada, K., Oka, K. & Kobayashi, M. (1995) In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J. Neurochem., 65, 2790-2795.
49. Wolf, M.E. & Roth, R.H. (1990) Autoreceptor regulation of dopamine synthesis. Ann. N.Y. Acad. Sci., 604, 323-343.
50. Yan, Y., Chi, P.P. & Bourne, H.R. (1997) RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis. J. Biol. Chem., 272, 11 924-11 927.